Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

P Ficarra

Showing results (41-50 of 52) with videos related to

Pageof 6
Sort By:
Journal of Pharmaceutical and Biomedical Analysis|May 8, 2007
The enhancement of isoflavones water solubility by complexation with modified cyclodextrins: a spectroscopic investigation with implications in the pharmaceutical analysisR Stancanelli, A Mazzaglia, S Tommasini, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 12, 2002
An experimental design methodology applied to the enantioseparation of a non-steroidal anti-inflammatory drug candidateR Ficarra, P Cutroneo, Z Aturki, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 12, 2002
Validation of a LC method for the analysis of oxaliplatin in a pharmaceutical formulation using an experimental designR Ficarra, M L Calabrò, P Cutroneo, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 18, 2000
Study of the inclusion complex of atenolol with beta-cyclodextrinsR Ficarra, P Ficarra, M R Di Bella, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 30, 2005
The inclusion complexes of hesperetin and its 7-rhamnoglucoside with (2-hydroxypropyl)-beta-cyclodextrinS Tommasini, M L Calabrò, R Stancanelli, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 12, 2002
Study of flavonoids/beta-cyclodextrins inclusion complexes by NMR, FT-IR, DSC, X-ray investigationR Ficarra, S Tommasini, D Raneri, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 18, 2000
Study of beta-blockers/beta-cyclodextrins inclusion complex by NMR, DSC, X-ray and SEM investigationR Ficarra, P Ficarra, M R Di Bella, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 29, 2004
The rutin/beta-cyclodextrin interactions in fully aqueous solution: spectroscopic studies and biological assaysM L Calabrò, S Tommasini, P Donato, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 25, 2006
Optimization of a LC method for the enantioseparation of a non-competitive glutamate receptor antagonist, by experimental design methodologyP Donato, R Stancanelli, M L Calabrò, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 11, 2008
UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complexR Stancanelli, R Ficarra, C Cannavà, et al.
Pageof 6

Showing results (41-50 of 52) with videos related to

Sort By:
Pageof 6
Journal of Pharmaceutical and Biomedical Analysis|May 8, 2007
The enhancement of isoflavones water solubility by complexation with modified cyclodextrins: a spectroscopic investigation with implications in the pharmaceutical analysisR Stancanelli, A Mazzaglia, S Tommasini, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 12, 2002
An experimental design methodology applied to the enantioseparation of a non-steroidal anti-inflammatory drug candidateR Ficarra, P Cutroneo, Z Aturki, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 12, 2002
Validation of a LC method for the analysis of oxaliplatin in a pharmaceutical formulation using an experimental designR Ficarra, M L Calabrò, P Cutroneo, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 18, 2000
Study of the inclusion complex of atenolol with beta-cyclodextrinsR Ficarra, P Ficarra, M R Di Bella, et al.
Journal of Pharmaceutical and Biomedical Analysis|June 30, 2005
The inclusion complexes of hesperetin and its 7-rhamnoglucoside with (2-hydroxypropyl)-beta-cyclodextrinS Tommasini, M L Calabrò, R Stancanelli, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 12, 2002
Study of flavonoids/beta-cyclodextrins inclusion complexes by NMR, FT-IR, DSC, X-ray investigationR Ficarra, S Tommasini, D Raneri, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 18, 2000
Study of beta-blockers/beta-cyclodextrins inclusion complex by NMR, DSC, X-ray and SEM investigationR Ficarra, P Ficarra, M R Di Bella, et al.
Journal of Pharmaceutical and Biomedical Analysis|December 29, 2004
The rutin/beta-cyclodextrin interactions in fully aqueous solution: spectroscopic studies and biological assaysM L Calabrò, S Tommasini, P Donato, et al.
Journal of Pharmaceutical and Biomedical Analysis|July 25, 2006
Optimization of a LC method for the enantioseparation of a non-competitive glutamate receptor antagonist, by experimental design methodologyP Donato, R Stancanelli, M L Calabrò, et al.
Journal of Pharmaceutical and Biomedical Analysis|April 11, 2008
UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complexR Stancanelli, R Ficarra, C Cannavà, et al.
Pageof 6